Ultrasound-mediated gene delivery specifically targets liver sinusoidal endothelial cells for sustained FVIII expression in hemophilia A mice.

ABSTRACT: The ability to target the native production site of factor VIII (FVIII)-liver sinusoidal endothelial cells (LSECs)-can improve the outcome of hemophilia A (HA) gene therapy. By testing a matrix of ultrasound-mediated gene delivery (UMGD) parameters for delivering a GFP plasmid into the livers of HA mice, we were able to define specific conditions for targeted gene delivery to different cell types in the liver. Subsequently, two conditions were selected for experiments to treat HA mice via UMGD of an endothelial-specific human FVIII plasmid: low energy (LE; 50 W/cm², 150 μs pulse duration) to predominantly target endothelial cells or high energy (HE; 110 W/cm², 150 μs pulse duration) to predominantly target hepatocytes. Both groups of UMGD-treated mice achieved persist

SUBMITTER: Lawton SM 

PROVIDER: S-EPMC11163219 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature